Welcome to The Oncology Expert Exchange. This freely accessible resource provides a range of CE activities across the spectrum of oncology and hematology/oncology conditions. Our goal is to ensure that you – the practicing clinician – have the most accurate, up-to-date information on the diagnosis, management, and treatment strategies for solid and hematological malignancies.
We encourage you to share this educational resource with your colleagues and your healthcare team.
Displaying 14 courses
Acute Myeloid Leukemia (1 course)
Optimizing Outcomes for AML Patients Ineligible for Intensive Therapy: Individualizing Treatment Selection and Management
Disease State: Acute Myeloid Leukemia
Expiration Date: Aug. 21, 2024
Multiple Myeloma (1 course)
Transforming Progress Into Action in Relapsed/Refractory Multiple Myeloma: Improving Patient Outcomes Through Innovative Bispecific Antibodies
Disease State: Multiple Myeloma
Expiration Date: Jun. 17, 2025
Prostate Cancer (1 course)
Exploring the Next Frontier in mCRPC: The Power and Promise of EZH2 Inhibitors to Combat Resistance to Androgen Inhibitors
Disease State: Prostate Cancer
Expiration Date: Apr. 25, 2026
Acute Lymphoblastic Leukemia (1 course)
Improving Outcomes for Adolescent/Young Adult and Adult Patients with ALL: Evaluating the Impact of Immunotherapy
Disease State: Acute Lymphoblastic Leukemia
Expiration Date: Dec. 12, 2023
Breast Cancer (10 courses)
Individualizing Treatment Selection, Sequencing, & Management in HER2+ MBC – A Clinical Case Challenge Activity
Disease State: Breast Cancer
Expiration Date: Jul. 14, 2026
Managing Brain Metastases in HER2+ MBC: Integrating Cutting Edge Advances into Practice – A Clinical Case Challenge Activity
Disease State: Breast Cancer
Expiration Date: Jul. 14, 2026
Perspectives on Treatment Selection and Sequencing in HER2+ MBC: A Data Dive and Discussion
Disease State: Breast Cancer
Expiration Date: Jul. 14, 2026
“PI3K-ing” the Right Treatment: Advances in PI3K Inhibition in HR+/HER2- Metastatic Breast Cancer
Disease State: Breast Cancer
Expiration Date: Jun. 30, 2026
Overcoming Mechanisms of Resistance in HR+/HER2- Advanced Breast Cancer: Exploring AKT Inhibitors, Oral SERDs, and Other New Therapy Classes
Disease State: Breast Cancer
Expiration Date: Dec. 22, 2024
The Nurse’s Role in Care Coordination and Multidisciplinary Care for HR+/HER2 – EBC
Disease State: Breast Cancer
Expiration Date: Nov. 28, 2023
Engaging Patients in Care: Strategies for Shared Decision-making and Patient Education
Disease State: Breast Cancer
Expiration Date: Nov. 28, 2023
Nurse-led Strategies to Overcome Barriers to Adherence and Persistence to Oral Therapies in HR+/HER2- EBC
Disease State: Breast Cancer
Expiration Date: Nov. 28, 2023
Adverse Event Management of Oral Therapies in HR+/HER2- EBC
Disease State: Breast Cancer
Expiration Date: Nov. 28, 2023
CDK4/6 Inhibitors in HR+/HER2-EBC: Updates in Adjuvant Therapy Paradigms for High Risk Disease
Disease State: Breast Cancer
Expiration Date: Nov. 28, 2023
Hematological Malignancies (3 courses)
Improving Outcomes for Adolescent/Young Adult and Adult Patients with ALL: Evaluating the Impact of Immunotherapy
Disease State: Acute Lymphoblastic Leukemia
Expiration Date: Dec. 12, 2023
Optimizing Outcomes for AML Patients Ineligible for Intensive Therapy: Individualizing Treatment Selection and Management
Disease State: Acute Myeloid Leukemia
Expiration Date: Aug. 21, 2024
Transforming Progress Into Action in Relapsed/Refractory Multiple Myeloma: Improving Patient Outcomes Through Innovative Bispecific Antibodies
Disease State: Multiple Myeloma
Expiration Date: Jun. 17, 2025